Mice without telomerase: what can they teach us about human cancer? - PubMed (original) (raw)
Review
doi: 10.1038/78595.
Affiliations
- PMID: 10932211
- DOI: 10.1038/78595
Review
Mice without telomerase: what can they teach us about human cancer?
S E Artandi et al. Nat Med. 2000 Aug.
Abstract
Unicellular organisms, human cells and mice have provided insights into the processes of senescence, crisis, genomic instability and cancer in humans. Here, Artandi and DePinho discuss how studies in mice have uncovered a complex interplay between the ARF-p53 pathway, genomic instability due to telomere dysfunction, and the suppression or promotion of cancer.
Similar articles
- Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology.
Wright WE, Shay JW. Wright WE, et al. Nat Med. 2000 Aug;6(8):849-51. doi: 10.1038/78592. Nat Med. 2000. PMID: 10932210 Review. - Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.
Hackett JA, Greider CW. Hackett JA, et al. Oncogene. 2002 Jan 21;21(4):619-26. doi: 10.1038/sj.onc.1205061. Oncogene. 2002. PMID: 11850787 Review. - [1997, a good year for telomerase?].
Gilson E. Gilson E. Bull Cancer. 1998 Feb;85(2):119-23. Bull Cancer. 1998. PMID: 9752327 French. - Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
Farazi PA, Glickman J, Horner J, Depinho RA. Farazi PA, et al. Cancer Res. 2006 May 1;66(9):4766-73. doi: 10.1158/0008-5472.CAN-05-4608. Cancer Res. 2006. PMID: 16651430 - Telomerase is not an oncogene.
Harley CB. Harley CB. Oncogene. 2002 Jan 21;21(4):494-502. doi: 10.1038/sj.onc.1205076. Oncogene. 2002. PMID: 11850774 Review.
Cited by
- Aging of the progenitor cells that initiate prostate cancer.
Freeland J, Crowell PD, Giafaglione JM, Boutros PC, Goldstein AS. Freeland J, et al. Cancer Lett. 2021 Sep 1;515:28-35. doi: 10.1016/j.canlet.2021.05.014. Epub 2021 May 28. Cancer Lett. 2021. PMID: 34052326 Free PMC article. Review. - mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration.
Chanda PK, Sukhovershin R, Cooke JP. Chanda PK, et al. Cells. 2021 Jan 19;10(1):187. doi: 10.3390/cells10010187. Cells. 2021. PMID: 33477787 Free PMC article. Review. - TINF2 is a haploinsufficient tumor suppressor that limits telomere length.
Schmutz I, Mensenkamp AR, Takai KK, Haadsma M, Spruijt L, de Voer RM, Choo SS, Lorbeer FK, van Grinsven EJ, Hockemeyer D, Jongmans MC, de Lange T. Schmutz I, et al. Elife. 2020 Dec 1;9:e61235. doi: 10.7554/eLife.61235. Elife. 2020. PMID: 33258446 Free PMC article. - Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
Gu P, Wang Y, Bisht KK, Wu L, Kukova L, Smith EM, Xiao Y, Bailey SM, Lei M, Nandakumar J, Chang S. Gu P, et al. Oncogene. 2017 Apr 6;36(14):1939-1951. doi: 10.1038/onc.2016.405. Epub 2016 Nov 21. Oncogene. 2017. PMID: 27869160 Free PMC article. - Mitochondrial dysfunction and oxidative stress in aging and cancer.
Kudryavtseva AV, Krasnov GS, Dmitriev AA, Alekseev BY, Kardymon OL, Sadritdinova AF, Fedorova MS, Pokrovsky AV, Melnikova NV, Kaprin AD, Moskalev AA, Snezhkina AV. Kudryavtseva AV, et al. Oncotarget. 2016 Jul 19;7(29):44879-44905. doi: 10.18632/oncotarget.9821. Oncotarget. 2016. PMID: 27270647 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous